Brain study reveals cause of apathy in schizophrenia

Plus, news about RF Ac­qui­si­tion Corp II, Skye Bio­science, Cog­ni­tion Ther­a­peu­tics, Siol­ta Ther­a­peu­tics and Tier­ra Bio­sciences: Reg­u­lus Ther­a­peu­tics’ PhI da­ta and $100M raise: The com­pa­ny’s

The team developing treatments for Parkinson’s disease by targeting the gut microbiome and gut-brain axis. Credit: Queensland University of Technology. Scientists of Queensland University of